Turning Point Therapeutics, Inc.

TPTX · NASDAQ
Analyze with AI
$75.49+$0.09 (+0.12%)
At close:Aug 15, 2022, 8:00 PM UTC
P/E TTM-13.03
P/B TTM3.23
P/S TTM0
Dividend Yield0%
EPS-$5.57
Beta-0.194064
Valuation
PEG Ratio-0.13
FCF Yield
EV / EBITDA1.82
Quality
ROIC-24.79%
Gross Margin100.00%
Cash Conv. Ratio0.76
Growth
Revenue 3Y CAGR
FCF Growth-85.96%
Safety
Net Debt / EBITDA1.82
Interest Coverage0.00
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle0.00

Turning Point Therapeutics, Inc. (TPTX) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Turning Point Therapeutics, Inc. (TPTX) stock price today?

As of Aug 15, 2022, 8:00 PM UTC, Turning Point Therapeutics, Inc. (TPTX) stock is trading at $75.49. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date TPTX stock quotes for informed trading decisions.

What is Turning Point Therapeutics, Inc.'s market capitalization?

Current market capitalization data for Turning Point Therapeutics, Inc. (TPTX) is not available at this moment. Market cap depends on the latest share count and stock price from Financial Modeling Prep. This information typically updates after regulatory filings are processed.

What is the 52-week range for Turning Point Therapeutics, Inc. stock?

Turning Point Therapeutics, Inc. (TPTX) stock has traded in a 52-week range of $0.00 — $0.00. The 52-week range shows the highest and lowest prices at which TPTX traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Turning Point Therapeutics, Inc. stock price to this range provides context for recent price action.

How much trading volume does Turning Point Therapeutics, Inc. stock have?

Turning Point Therapeutics, Inc. (TPTX) stock recently traded approximately 1M shares. Trading volume indicates market liquidity and investor interest in TPTX. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Turning Point Therapeutics, Inc. stock.

Does Turning Point Therapeutics, Inc. pay dividends to shareholders?

Yes, Turning Point Therapeutics, Inc. (TPTX) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Turning Point Therapeutics, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Turning Point Therapeutics, Inc.'s intraday price range?

Today, Turning Point Therapeutics, Inc. (TPTX) stock has traded in a range of $75.30 — $75.77. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring TPTX's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Turning Point Therapeutics, Inc. stock data?

AlphaPilot sources real-time TPTX stock quotes, fundamental financial data, and historical price charts for Turning Point Therapeutics, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Turning Point Therapeutics, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of TPTX stock performance.